Literature DB >> 1221924

Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus.

J Holian, I D Griffiths, D N Glass, R N Maini, J T Scott.   

Abstract

A technique for the measurement of DNA binding activity of sera is described which uses primary internal reference standards in a Farr assay. This allows the DNA binding activity of test sera to be measured in relation to the reference standards and the results are expressed as units/ml. The use of this standardized assay has led to diminished interassay variation and close interlaboratory correlation, and has provided a clinically useful test. In survey using the standardized assay, normal sera were found to have binding activity which did not exceed 15 units/ml; 71% of patients with systemic lupus erythematosus (SLE) had levels greater than 25 units/ml; while only 8% of patients with diseases other than SLE had levels above 25 units/ml. Values between 15 and 25 units/ml appeared to have little diagnostic significance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1221924      PMCID: PMC1006445          DOI: 10.1136/ard.34.5.438

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  A DNA-reacting factor in serum of a patient with lupus erythematosus diffusus.

Authors:  R CEPPELLINI; E POLLI; F CELADA
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

2.  Native DNA binding in rheumatoid arthritis.

Authors:  P G Rochmis; H Palefsky; M Becker; H Roth; N J Zvaifler
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

3.  Serum DNA binding activity in healthy subjects and in rheumatic disease.

Authors:  P Hasselbacher; E C LeRoy
Journal:  Arthritis Rheum       Date:  1974 Jan-Feb

4.  Significance of anti-D.N.A. antibodies in systemic lupus erythematosus.

Authors:  G R Hughes
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

5.  Character of anti-DNA antibodies in systemic lupus erythematosus.

Authors:  S A Cohen; G R Hughes; G L Noel; C L Christian
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

6.  Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors:  P H Schur; J Sandson
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

7.  Deoxyribonucleic acid antibody: a method to detect its primary interaction with deoxyribonucleic acid.

Authors:  R T Wold; F E Young; E M Tan; R S Farr
Journal:  Science       Date:  1968-08-23       Impact factor: 47.728

8.  Studies on DNA antibodies using DNA labelled with actinomycin-D (3H) or dimethyl (3H) sulphate.

Authors:  R I Carr; D Koffler; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1969-05       Impact factor: 4.330

9.  Measurement of serum DNA-binding activity in systemic lupus erythematosus.

Authors:  T Pincus; P H Schur; J A Rose; J L Decker; N Talal
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

10.  The precipitin reaction between DNA and a serum factor in systemic lupus erythematosus.

Authors:  H R DEICHER; H R HOLMAN; H G KUNKEL
Journal:  J Exp Med       Date:  1959-01-01       Impact factor: 14.307

View more
  21 in total

1.  Sulphasalazine-induced lupus syndrome in ulcerative colitis.

Authors:  I D Griffiths; S P Kane
Journal:  Br Med J       Date:  1977-11-05

2.  Evaluation of the simultaneous estimation of anti-dsDNA and anti-ssDNA antibodies for clinical purposes.

Authors:  A Lange
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

3.  Evaluation of a standardised assay for the measurement of antibodies to double-stranded (native) DNA.

Authors:  P Davis; M Burrington; A R Morgan; A Saetre
Journal:  J Clin Pathol       Date:  1977-09       Impact factor: 3.411

4.  Serum levels of interferons in patients with systemic lupus erythematosus.

Authors:  T Kim; Y Kanayama; N Negoro; M Okamura; T Takeda; T Inoue
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

5.  [The Crithidia luciliae immunofluorescence test for detection of antibodies to double-stranded DNA (author's transl)].

Authors:  P Herzer; G Greif; E M Lemmel
Journal:  Klin Wochenschr       Date:  1982-02-01

6.  Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.

Authors:  B Combe; M Rucheton; H Graafland; V Lussiez; C Brunel; J Sany
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  The significance of antibodies to poly(adenosine diphosphate-ribose) in systemic lupus erythematosus.

Authors:  E E Okolie; S Shall
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

8.  Measurement of antibody to poly (adenosine diphosphate-ribose): its diagnostic value in systemic lupus erythematosus.

Authors:  A L Clayton; R M Bernstein; M Tavassoli; S Shall; C Bunn; G R Hughes; S M Chantler
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

9.  Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.

Authors:  C C Erhardt; P Mumford; R N Maini
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

10.  DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.

Authors:  D Adu; J Dobson; D G Williams
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.